Clinical Trial Update: Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating serlopitant for pruritus associated with prurigo nodularis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis
• Pruritus

Drugs mentioned

• Serlopitant (serlopitant)

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Pruritus, Prurigo Nodularis | Phase 3 | Status: COMPLETED | Results posted: 2020-09-07